that

Medical Value Travel (MVT) acts as channel of cooperation that builds confidence, strengthens people-to-people ties between nation

Integrated care model with advanced clinical excellence with Ayush is strengthening India's Global Appeal: Prataprao Jadhav, MoS (I/C), Health and…

3 months ago

Denmark Street Icon Regent Sounds, Announces Exclusive Online Sale of T-Bone Walker’s Legendary 1949 Gibson ES-5N: “The Guitar That Started It All” on Reverb

LONDON, Feb. 23, 2026 /PRNewswire/ -- The newly reopened Regent Sounds guitar shop on Denmark Street will mark the launch…

3 months ago

Coca-Cola India Brings Back Rimzim Jeera with a New Campaign that Refuses to be Subtle

NEW DELHI, Feb. 20, 2026 /PRNewswire/ -- India rediscovers its love for local flavours, Coca-Cola is bringing back its cult…

3 months ago

India’s Biggest Tech Awards Are Back: Featuring the Gadgets That Changed Lives

This year's edition features 20+ award categories with over 40 leading brands competing across segments. This will also be the…

3 months ago

Kiteskraft unveils their latest publication, The Power List to announce the mentors and change-makers that are shaping progress in India

CHANDIGARH, India, Feb. 12, 2026 /PRNewswire/ -- Kiteskraft Productions LLP proudly presents The Power List: Minds and Missions Redefining Success…

3 months ago

AB Science announced that the Food and Drug Administration (FDA) granted the status of Minor Use in Major Species (MUMS) for Masivet in the treatment of canine mast cell tumors

PRESS RELEASE AB SCIENCE ANNOUNCES THAT THE FDA HAS GRANTED THE STATUS OF MINOR USE IN MAJOR SPECIES DESIGNATION FOR…

3 months ago

Aptean Unveils Aptean Intelligence as a Service, Delivering IndustryReady AI Agents That Drive Real Operational Results

ALPHARETTA, Ga., Feb. 09, 2026 (GLOBE NEWSWIRE) -- As manufacturers and distributors move beyond AI experimentation, Aptean, a global leader…

3 months ago

Roches fenebrutinib is the first investigational medicine in over a decade that reduces disability progression in primary progressive multiple sclerosis (PPMS)

Late-breaking Phase III FENtrepid results presented at ACTRIMS show investigational fenebrutinib met its primary endpoint of non-inferiority compared to the…

4 months ago

Moleac is pleased to announce that NeuroAiDII has been awarded Gold accreditation by Empowered By Evidence.

SINGAPORE, Feb. 5, 2026 /PRNewswire/ -- This recognition reflects the robust clinical evidence supporting NeuroAiD™II, as well as the uniqueness…

4 months ago

Helix Alpha Systems Ltd Engineers Quantitative Research for Markets That Cannot Be Forecast

London, UK, Jan. 30, 2026 (GLOBE NEWSWIRE) -- For decades, quantitative finance has operated on the assumption that markets can…

4 months ago